Return To Mondaq Homepage Pharmaceutical, Healthcare & Life Sciences
Preview most recent added content
Login
Register for Free
First Time Here?

 
Mondaq Topics
 
Our Services
 
About This Site
 
Advertise with Us
Unsubscribe
Copyright
Welcome to Europe
Home Page About Search Europe Browse Site
Your first time here? Click here for a quick guide to our website.

Here you will find the latest thinking on legal, accounting, regulatory and commercial issues supplied by the world's leading professional advisors.

If you are a professional advisor yourself (for example you are part of a law firm, consultancy group or accountancy firm), and your organisation writes articles, please click here.

Below are the lastest articles on Pharmaceutical, Healthcare & Life Sciences from Europe Briefing. Different topic options are on the left; different regional options are at the top of the page. Alternatively you can search our database for articles by date, topic, firm, country, author, free text, etc.

You are currently viewing content on this site filtered by the topic of Pharmaceutical, Healthcare & Life Sciences. If you would like to remove this filter, click here

Free Personalized News Alerts
Keep up to date with the most recently added articles to Mondaq in accordance with your topic preferences.
>Signup<
Hot Topics Headlines

Top 10 Pharmaceutical, Healthcare & Life Sciences Headlines from Europe

New measures for foreign currency loans and foreign currency indexed loans.
To sell a medicine in the European Union (EU), a marketing authorisation (MA) is required.
Draft laws published by the BRSA: The BRSA has published two draft laws on its web site. The first draft foresees various amendments in the Banking Law. The second draft foresees a new law on the establishment/operation of finance leasing, factoring and finance companies.
Research and Development (“R&D”) activities are an investment field that has become more of an issue in Turkey in recent years.
On 6 October 2009, the European Court of Justice (ECJ) issued its judgment in the long-running wrangle regarding the legality of GlaxoSmithKline's (GSK) dual pricing arrangements with Spanish pharmaceutical wholesalers.
Bureaucratic burden and uncertainties caused by lack of sufficient and relevant regulation were blamed by the pharmaceutical industry as one of the significant reasons for the relatively low number of clinical trials conducted in Turkey despite its potential in terms of population, qualified personnel and geographical location.
The map of European pricing and reimbursement systems is quitecomplex.
New price controls for life-saving and essential medicines have been introduced by the government.
Originators beware: The marketing authorization granted by theGerman authority for a generic formulation of Plavix, and thesubsequent decision of the competent court in preliminaryproceedings to allow the marketing of the drug, raises questionsabout the protection of data under the European regulatoryframework.
In Turkey, the advertising matter of pharmaceutical products is governed by the Regulation on the Promotion of the Medicinal Products for Human Use which is based on Pharmaceutical and Medical Preparations Law numbered 1262.
Latest News from Pharmaceutical, Healthcare & Life Sciences
in Europe
Our most popular article this week:
Clinical Trials And Technology Development Areas In The Research And Development World
from Pharmaceutical, Healthcare & Life Sciences in Europe
by Mehmet Gun & Partners.
View Recent Headlines Covering    

© Mondaq® 1994-2009.
All Rights Reserved